< Back to previous page
Researcher
Peter Hellings
- Disciplines:Immunology, Laboratory medicine
Affiliations
- Research Group Experimental Oto-rhino-laryngology (Division)
Member
From1 Oct 2003 → 31 Dec 2011 - Allergy and Clinical Immunology Research Group (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 10 of 21
- Towards better care for chronic sinus disease and comorbiditiesFrom10 Apr 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Basal Instinct; towards a better understanding of basal cell function in chronic rhinosinusitis with nasal polypsFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The bittersweet taste of bacteria in the nose of patients with chronic rhinosinusitis with nasal polyps.From1 Oct 2021 → TodayFunding: FWO junior postdoctoral fellowship
- Towards better CRS care by better understanding the mechanism of novel therapeutic approaches that modulate the mucosal epithelial barrierFrom18 Aug 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- N-ERD PROJECT 2020: Paving the Future for Better and Cost-effective Care for Severe CRSwNP PatientsFrom11 Jan 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Unraveling the dialog between airway basal cells and immunity in health and allergic rhinitisFrom6 Jan 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- N-ERD PROJECT 2020: PAVING THE FUTURE FOR BETTER AND COST-EFFECTIVE CARE FOR SEVERE CRSwNP PATIENTSFrom1 Jan 2021 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Further confirmation of the therapeutic potential of Toll Like Receptor 9 (TLR9) antagonists on type 2 airway Inflammation: allergic rhinitis (AR) and chronic rhinosinusitis with nasal polyps (CRSwNP)From1 Oct 2020 → 30 Sep 2022Funding: IOF - technology validation in lab
- Investigation of the role of neuroendocrine cells in neuronal hyperexcitability in non-allergic respiratory diseases.From1 Sep 2020 → TodayFunding: FWO fellowships
- Neuro-immune mechanisms of visceral and respiratory hypersensitivityFrom1 Oct 2018 → 30 Sep 2022Funding: IOF - Industrial Research Fund, Fund Recuperation Fiscal Exemption
Publications
31 - 40 of 429
- Allergen provocation tests in respiratory research: building on 50 years of experience(2022)
Authors: Peter Hellings
- Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps(2022)
Authors: Peter Hellings
Pages: 958 - 962 - Digital tools in allergy and respiratory care(2022)
Authors: Peter Hellings
- SWOT Analysis of Chronic Rhinosinusitis Care Anno 2022(2022)
Authors: Peter Hellings
Pages: 468 - 471 - WAO-ARIA consensus on chronic cough - Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19(2022)
Authors: Peter Hellings
- Epithelial and sensory mechanisms of nasal hyperreactivity(2022)
Authors: Peter Hellings, Laura Van Gerven, Karel Talavera Pérez
Pages: 1450 - 1463 - Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps(2022)
Authors: Peter Hellings
Pages: 1086 - + - Dupilumab in CRSwNP: Responder Analysis Using Clinically Meaningful Efficacy Outcome Thresholds(2022)
Authors: Peter Hellings
Pages: 259 - 264 - Estimating Clinically Meaningful Change of Efficacy Outcomes in Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyposis(2022)
Authors: Peter Hellings
Pages: 265 - 271 - Mepolizumab improves quality of life and reduces activity impairments in patients with CRSwNP(2022)
Authors: Peter Hellings
Patents
1 - 2 of 2